What to Expect
Gold Sponsor Servier is pleased to host their 2025 Early Innovation Award at LabCentral! This Golden Ticket will go to a startup who is driving scientific innovation in areas of high unmet need, including hard-to-treat diseases in oncology, neuroscience, and those pursuing research in translational medicine, drug development technologies, and drug delivery platforms. Come and network while supporting the competing companies!
Gold Sponsor Servier is pleased to host their 2024 Early Innovation Award at LabCentral! This Golden Ticket will go to a startup who is driving scientific innovation in areas of high unmet need, including hard-to-treat diseases in oncology, neuroscience, and immuno-inflammation, as well as those pursuing research in translational medicine, drug development technologies, and drug delivery platforms. Come and network while supporting the competing companies!
Agenda
4:00 PM: Registration and networking
4:30 PM: Opening remarks and Fireside Chat
4:55 PM: Pitches begin
5:25 PM: Judges Deliberation
5:30 PM: Winner Announcement
5:35 PM: Networking
7:00 PM: Event close
4 PM: Registration and networking
4:30 PM: Opening remarks
4:50 PM: Pitches begin
5:25 PM: Judges Deliberation
5:30 PM: Winner Announcment
5:35 PM: Networking
7PM: Event close
Finalists
Speakers
Chloe Leprete
Head of Search & Evaluation at Servier
Helene Tran
Director, Head of Antisense Oligonucleotide Therapeutics Program, Neurology.
Dale Porter
Head of Oncology Research at Servier Pharmaceuticals
Judges
Olga Kolman, MD
Head of US Portfolio Strategy at Servier Pharmaceuticals
Pat Fetaya
Head of Business Development at Servier Pharmaceuticals
Justin Cidado, PhD
Senior Director Head of US Cancer Biology